We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

EX-10.7 8 a2213875zex-10_7.htm EX-10.7 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested under 17 C.F.R. Sections 200.80(b)(4) and 230.406 BAYER AG and GW PHARMA LTD SUPPLY AGREEMENT...